Viewing data from:

FLUDEOXYGLUCOSE F18

ANDA

FLUDEOXYGLUCOSE F-18 | A203246 | UNIV TEXAS MD ANDERSON CANCER CENTER

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: FLUDEOXYGLUCOSE F18

API Supply Chain0 active DMFs2 inactive

0 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

INSTITUTE CLINICAL PETInactiveFLUDEOXYGLUCOSE F-18 INJECTION

DMF 90571991

GENERAL ELECTRIC MEDICAL SYSTEMSInactiveFLUDEOXYGLUCOSE F-18 INJECTION

DMF 132681998

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 20-150mCi/ML

0 patents0 exclusivities▴

INJECTABLE;INTRAVENOUS | Approved: Jan 13, 2014

No patent or exclusivity listings for this strength.

#002 — 20-300mCi/ML

0 patents0 exclusivities▾

INJECTABLE;INTRAVENOUS | Approved: Jan 13, 2014